These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 22982982

  • 1. Fatal wild-type varicella-zoster virus encephalitis without a rash in a vaccinated child.
    Ibraheem M, Marin M, Leung J, Bryce CH, Schmid DS, Zaki SR, Drew C, Liu L, Smelser C.
    Pediatr Infect Dis J; 2013 Feb; 32(2):183-5. PubMed ID: 22982982
    [Abstract] [Full Text] [Related]

  • 2. Varicella-zoster virus in children immunized with the varicella vaccine.
    Chesnut G, McClain D, Galeckas K.
    Cutis; 2012 Sep; 90(3):114-6. PubMed ID: 23094307
    [Abstract] [Full Text] [Related]

  • 3. Severe meningoencephalitis due to late reactivation of Varicella-Zoster virus in an immunocompetent child.
    Spiegel R, Miron D, Lumelsky D, Horovitz Y.
    J Child Neurol; 2010 Jan; 25(1):87-90. PubMed ID: 19494359
    [Abstract] [Full Text] [Related]

  • 4. The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group.
    Hardy I, Gershon AA, Steinberg SP, LaRussa P.
    N Engl J Med; 1991 Nov 28; 325(22):1545-50. PubMed ID: 1658650
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Varicella-zoster virus meningoencephalitis in an immunocompetent patient without a rash.
    Klein NC, McDermott B, Cunha BA.
    Scand J Infect Dis; 2010 Aug 28; 42(8):631-3. PubMed ID: 20214542
    [Abstract] [Full Text] [Related]

  • 7. Rapid molecular discrimination between infection with wild-type varicella-zoster virus and varicella vaccine virus.
    Lässker U, Harder TC, Hufnagel M, Suttorp M.
    Infection; 2002 Oct 28; 30(5):320-2. PubMed ID: 12382096
    [Abstract] [Full Text] [Related]

  • 8. Varicella-zoster meningoencephaloradiculoneuropathy in an immunocompetent young woman.
    Mantero V, De Toni Franceschini L, Lillia N, Guccione A, Santilli I, Agostoni E.
    J Clin Virol; 2013 Aug 28; 57(4):361-2. PubMed ID: 23778237
    [Abstract] [Full Text] [Related]

  • 9. Laboratory characteristics of suspected herpes zoster in vaccinated children.
    Chun C, Weinmann S, Riedlinger K, Mullooly JP, Houston H, Schmid DS, Seward JF.
    Pediatr Infect Dis J; 2011 Aug 28; 30(8):719-21. PubMed ID: 21346684
    [Abstract] [Full Text] [Related]

  • 10. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?
    Lopez AS, Guris D, Zimmerman L, Gladden L, Moore T, Haselow DT, Loparev VN, Schmid DS, Jumaan AO, Snow SL.
    Pediatrics; 2006 Jun 28; 117(6):e1070-7. PubMed ID: 16740809
    [Abstract] [Full Text] [Related]

  • 11. Laboratory diagnosis and characteristics of breakthrough varicella in children.
    Weinmann S, Chun C, Mullooly JP, Riedlinger K, Houston H, Loparev VN, Schmid DS, Seward JF.
    J Infect Dis; 2008 Mar 01; 197 Suppl 2():S132-8. PubMed ID: 18419386
    [Abstract] [Full Text] [Related]

  • 12. Varicella-zoster virus acquired at 4 months of age reactivates at 24 months and causes encephalitis.
    Chiappini E, Calabri G, Galli L, Salvi G, de Martino M.
    J Pediatr; 2002 Feb 01; 140(2):250-1. PubMed ID: 11865281
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Development of varicella vaccine.
    Takahashi M, Asano Y, Kamiya H, Baba K, Ozaki T, Otsuka T, Yamanishi K.
    J Infect Dis; 2008 Mar 01; 197 Suppl 2():S41-4. PubMed ID: 18419406
    [Abstract] [Full Text] [Related]

  • 15. The safety profile of varicella vaccine: a 10-year review.
    Galea SA, Sweet A, Beninger P, Steinberg SP, Larussa PS, Gershon AA, Sharrar RG.
    J Infect Dis; 2008 Mar 01; 197 Suppl 2():S165-9. PubMed ID: 18419392
    [Abstract] [Full Text] [Related]

  • 16. Ten year follow-up of healthy children who received one or two injections of varicella vaccine.
    Kuter B, Matthews H, Shinefield H, Black S, Dennehy P, Watson B, Reisinger K, Kim LL, Lupinacci L, Hartzel J, Chan I, Study Group for Varivax.
    Pediatr Infect Dis J; 2004 Feb 01; 23(2):132-7. PubMed ID: 14872179
    [Abstract] [Full Text] [Related]

  • 17. An outbreak of varicella with likely breakthrough disease in a population of pediatric cancer patients.
    Adler AL, Casper C, Boeckh M, Heath J, Zerr DM.
    Infect Control Hosp Epidemiol; 2008 Sep 01; 29(9):866-70. PubMed ID: 18681813
    [Abstract] [Full Text] [Related]

  • 18. Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants.
    Hata A, Asanuma H, Rinki M, Sharp M, Wong RM, Blume K, Arvin AM.
    N Engl J Med; 2002 Jul 04; 347(1):26-34. PubMed ID: 12097537
    [Abstract] [Full Text] [Related]

  • 19. Central nervous system complications of varicella-zoster virus.
    Science M, MacGregor D, Richardson SE, Mahant S, Tran D, Bitnun A.
    J Pediatr; 2014 Oct 04; 165(4):779-85. PubMed ID: 25063723
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.